PMGC Holdings Inc.

ELAB

NASDAQ

Healthcare

Biotechnology

Newport Beach, CA, US2 employeespmgcholdings.com

$5.50

-8.50(-60.72%)

Mkt Cap $97.2K

$1.67

$1374.72

52-Week Range

At a Glance

AI-generated

Revenue was $590.1K Gross Profit was $185.3K Net Income was -$7.7M (-24.0%) Gross Margin was 31.4%

Revenue breakdown: IT Packaging Solutions (63.5%), Precision Engineering And Machining (36.5%).

8-K

PMGC Holdings Inc. announced the formation of a new wholly owned subsidiary, NorthStrive Defense Tech LLC, to target the defense technology sector with an emphasis on drone and autonomous systems.

$97.2K

Market Cap

-$1M

Revenue

-$5M

Net Income

Employees2

Fundamentals

How The Business Makes Money

Revenue by Segment

IT Packaging Solutions63.5%($374.9K)

Precision Engineering And Machining36.5%($215.2K)

Activity

What Changed Recently

Material Agreement

Mar 26, 2026

Entry into a Material Definitive Agreement. Third Amendment to License Agreement between Northstrive Biosciences Inc. and MOA Life Plus Co., Ltd. As of March 24

Material Agreement

Mar 22, 2026

Entry into a Material Definitive Agreement. (a) Amendment No. 5 to the Consulting and Services Agreement for Non-Employee Chief Executive Officer with GB Capita

Material Agreement

Mar 2, 2026

Entry into a Material Definitive Agreement. On February 6, 2026 (“Effective Date”), the Company and an investor (“Investor”) consummated Secured Pre-Paid Purcha

Material Agreement

Feb 9, 2026

of this Form 8-K have the meanings set forth in the License Agreement. “Applicable Laws” means all laws, statutes, ordinances, codes, rules, regulations, and re

Regulation FD

Apr 1, 2026

, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or oth

Peer Companies

Company	Price	Change	Market Cap	P/E
MLECMoolec Science S.A.	$7.00	+11.46%	$5M	-4.4
NCELNewcelX Ltd.	$2.25	-4.26%	$1M	-0.5
DRMADermata Therapeutics, Inc...	$1.29	+7.38%	$878.3K	-0.2
VRAXVirax Biolabs Group Limit...	$0.17	-12.12%	$755.5K	-0.1
XRTXXORTX Therapeutics Inc.	$0.42	-1.60%	$580.9K	-1.1
ATXIAvenue Therapeutics, Inc.	$0.16	-40.72%	$523.7K	-0.2
WINTWindtree Therapeutics, In...	$0.01	+9.33%	$505.6K	—
BCTXZBriaCell Therapeutics Cor...	$0.11	-21.43%	$207.2K	-0.3

Company Profile

CIK0001840563

ISINUS73017P4090

CUSIP73017P300

Phone866 445 4886

Address120 Newport Center Drive, Newport Beach, CA, 92660, US

SEC EDGAR